Press Release

Assessment of the Anticonvulsants for Neuropathic Pain Market

TMRR, in its recently published market research study, provides an out-an-out analysis of the current and future prospects of the Anticonvulsants for Neuropathic Pain market over the forthcoming decade. The study thoroughly analyzes all-round prospects of the Anticonvulsants for Neuropathic Pain market in various regional markets. In addition, the report examines the political and economic scenarios in different regions and their impact on the overall dynamics of the Anticonvulsants for Neuropathic Pain market.

The study reveals that the Anticonvulsants for Neuropathic Pain market is expected to reach a value of ~US$XX in 2019 and grow at a CAGR of ~XX% between 2019 and 2029. Furthermore, the study provides a thorough analysis of the quantitative and qualitative aspects of the Anticonvulsants for Neuropathic Pain market across various geographies.

Request Sample Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=32&source=atm

Critical information that can be drawn from the Anticonvulsants for Neuropathic Pain market report:

  • Evaluation of the key success factors that are expected to propel the growth of the Anticonvulsants for Neuropathic Pain market
  • Recent technological advances and innovations relevant to the Anticonvulsants for Neuropathic Pain market
  • The growth potential of emerging market players in various regions
  • Current and upcoming trends expected to influence the growth of the Anticonvulsants for Neuropathic Pain market
  • Import-export and supply-demand ratio analysis of the Anticonvulsants for Neuropathic Pain

The report addresses the following queries pertaining to the Anticonvulsants for Neuropathic Pain market:

  1. What are the different organic and inorganic growth strategies adopted by players in the Anticonvulsants for Neuropathic Pain market?
  2. Which region is expected to dominate the Anticonvulsants for Neuropathic Pain market in terms of share in the forecast period?
  3. How are market players reducing their environmental footprint?
  4. What are the latest innovations in the Anticonvulsants for Neuropathic Pain market?
  5. What is the estimated value of the Anticonvulsants for Neuropathic Pain market in 2019?

Request For Discount On This Report @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=32&source=atm

Anticonvulsants for Neuropathic Pain Market Segmentation

The report bifurcates the Anticonvulsants for Neuropathic Pain market to offer a microscopic view of the various aspects of the market. The Anticonvulsants for Neuropathic Pain market is segmented on the basis of region, product type, end-user, and more.

Drivers and Restraints 

The increasing incidence of people with neuropathic pain is one of the major factors driving the anticonvulsants for neuropathic pain market. In addition, a high number of patients refractory to alternate treatment methods, increasing use of generic drugs compared to branded drugs, and a high rate of polypharmacy are some other factors driving the growth of this market. 

The development of novel drug molecules for neuropathic drug indications is also propelling the growth of this market. This is because less than 50% of the patients respond to existing drugs that are available for neuropathic drug indications. Moreover, these drugs are associated with a number of side effects, particularly when administered systemically. Hence, new drug variants that can provide convincing action mechanism will be a game changer in the global anticonvulsants for neuropathic pain market. 

Some of the newer anticonvulsant drugs for neuropathic pain include Depomed’s Gralise (gabapentin gastric-retention), which is available since 2011 and is a ‘once –daily’ formulation. XenoPort’s Horizant (gabapentin encarbil) was introduced in 2012 and is a “twice-daily’ formulation. 

Global Anticonvulsants for Neuropathic Pain Market: Advantages of Anticonvulsants 

Neuropathic pain can be managed by opioids such as morphine, non-steroidal anti-inflammatory drugs, and anticonvulsant drugs. Anticonvulsants are normally used to control epileptic seizures but may also be used for treating neuropathic pain conditions such as fibromyalgia and postherpetic neuralgia. Anticonvulsants impede seizures through multiple mechanisms such as: 

  • Functional obstruction of voltage-gated-calcium channels
  • Impediment of glutamergic neurotransmission
  • Functional obstruction of voltage-sodium channels
  • Direct or indirect enhancement of hindering GABAergic neurotransmission 

Companies Mentioned in report 

The report provides a detailed vendor landscape of the global anticonvulsants for neuropathic pain market with a business profile of major companies that operate in this market. These are Teva Pharmaceuticals, Depomed Inc., Janssen Pharmaceutical Inc., Cephalon Inc., GlaxoSmithKline plc, Novartis AG, Pfizer Inc., AbbVie Inc., and XenoPort Inc.

Customize This Report @ https://www.tmrresearch.com/sample/sample?flag=CR&rep_id=32&source=atm

Why Purchase From TMRR?

  • Reports curated using the latest research and analytical tools
  • A systematic and well-defined data collection process
  • 24/7 customer support
  • One of the fastest-growing market research firms in India
  • Swift, convenient, and efficient ordering process

This post was originally published on Crypto Coin Guardian